chr, start, end, ref, var, IARC Class,  Primary reference,  Secondary reference 
17, 41276061, 41276061, ,  C, 4 - Likely pathogenic,  Easton DF et al.. Am J Hum Genet. 81: 873-883. 2007.,  Tavtigian et al.. Human Mutation 29: 1342-1354. 2008. 
17, 41276049, 41276049, ,  C, 5 - Definitely pathogenic,  Sweet K et al.. Breast Cancer Res Treat. 119:737-743. 2010.,  Tavtigian et al.. Human Mutation 29: 1342-1354. 2008. 
17, 41267767, 41267767, ,  A, 5 - Definitely pathogenic,  Sweet K et al.. Breast Cancer Res Treat. 119:737-743. 2010.,  Tavtigian et al.. Human Mutation 29: 1342-1354. 2008. 
17, 41267762, 41267762, ,  C, 5 - Definitely pathogenic,  Sweet K et al.. Breast Cancer Res Treat. 119:737-743. 2010.,  Tavtigian et al.. Human Mutation 29: 1342-1354. 2008. 
17, 41267747, 41267747, ,  A, 5 - Definitely pathogenic,  Sweet K et al.. Breast Cancer Res Treat. 119:737-743. 2010.,  Tavtigian et al.. Human Mutation 29: 1342-1354. 2008. 
17, 41267746, 41267746, ,  A, 5 - Definitely pathogenic,  Sweet K et al.. Breast Cancer Res Treat. 119:737-743. 2010.,  Tavtigian et al.. Human Mutation 29: 1342-1354. 2008. 
17, 41267744, 41267744, ,  C, 1 - Not pathogenic or of no clinical significance,  Sweet K et al.. Breast Cancer Res Treat. 119:737-743. 2010.,  Tavtigian et al.. Human Mutation 29: 1342-1354. 2008. 
17, 41258504, 41258504, ,  G, 5 - Definitely pathogenic,  Spearman AD et al.. J Clin Oncol. 26:5393-5400. 2008.,  Tavtigian et al.. Human Mutation 29: 1342-1354. 2008. 
